Spoorthy Kulkarni

487 total citations
22 papers, 224 citations indexed

About

Spoorthy Kulkarni is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Spoorthy Kulkarni has authored 22 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Spoorthy Kulkarni's work include Blood Pressure and Hypertension Studies (7 papers), Hormonal Regulation and Hypertension (4 papers) and Heart Rate Variability and Autonomic Control (3 papers). Spoorthy Kulkarni is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Hormonal Regulation and Hypertension (4 papers) and Heart Rate Variability and Autonomic Control (3 papers). Spoorthy Kulkarni collaborates with scholars based in United Kingdom, United States and Sweden. Spoorthy Kulkarni's co-authors include Ian B. Wilkinson, Marie Fisk, James Goodman, Anne Weiss, Rona Smith, Morten Otto Alexander Sommer, Joseph Cheriyan, Vikas Kapil, Mark Glover and Kevin M. O’Shaughnessy and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hypertension.

In The Last Decade

Spoorthy Kulkarni

18 papers receiving 222 citations

Peers

Spoorthy Kulkarni

CCM

SURGE

NEURO

Javaria Ahmad United States

Daniel Rayner Canada

Cem Tanrıöver Türkiye

Gurpreet Johal United States

Anissa Atif Mirza India

Roshan Kumar Mahat India

Kota Vidyasagar India

Alessandro Collo Italy

Cleto Álvarez-Aguilar Mexico

Magda Łapińska Poland

Javaria Ahmad United States

Spoorthy Kulkarni

87 ×1.6

CCM

108 ×2.1

32 ×1.0

19 ×0.7

SURGE

57 ×2.3

NEURO

Citations per year, relative to Spoorthy Kulkarni Spoorthy Kulkarni (= 1×) peers Javaria Ahmad

Countries citing papers authored by Spoorthy Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Spoorthy Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spoorthy Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spoorthy Kulkarni more than expected).

Fields of papers citing papers by Spoorthy Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spoorthy Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spoorthy Kulkarni. The network helps show where Spoorthy Kulkarni may publish in the future.

Co-authorship network of co-authors of Spoorthy Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Spoorthy Kulkarni. A scholar is included among the top collaborators of Spoorthy Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spoorthy Kulkarni. Spoorthy Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hey, C & Spoorthy Kulkarni. (2025). Artificial intelligence in healthcare research: Research ethics perspective. British Journal of Clinical Pharmacology. 92(3). 1003–1007.

Kulkarni, Spoorthy & Peter S. Sever. (2025). Blood pressure variability: a review. Journal of Hypertension. 43(10). 1732–1732.

Ambery, Phil, Peter J. Greasley, Robert Menzies, et al.. (2024). Targeting the endothelium by combining endothelin-1 antagonism and SGLT-2 inhibition: better together?. Clinical Science. 138(11). 687–697. 1 indexed citations

Kulkarni, Spoorthy & Ian B. Wilkinson. (2024). Adrenoceptors and Hypertension. Handbook of experimental pharmacology. 285. 297–332. 1 indexed citations

Kulkarni, Spoorthy, et al.. (2024). Treating Lows: Management of Orthostatic Hypotension. Journal of Cardiovascular Pharmacology. 84(3). 303–315. 1 indexed citations

Goodman, James, et al.. (2024). Renal Autotransplantation for Uncontrolled Hypertension in Nonatherosclerotic Renal Artery Stenosis—2 Case Reports and a Brief Review of the Literature. Hypertension. 81(4). 669–675. 3 indexed citations

Kulkarni, Spoorthy, et al.. (2024). Statins. BMJ. 384. e072584–e072584. 6 indexed citations

Faconti, Luca, Spoorthy Kulkarni, Christian Delles, et al.. (2023). Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society. Journal of Human Hypertension. 38(1). 8–18. 11 indexed citations

Kulkarni, Spoorthy, Veronica Phillips, Szilárd Nemes, et al.. (2022). Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis. BMJ Open. 12(12). e061476–e061476. 30 indexed citations

10.

Kulkarni, Spoorthy, Angela Wood, Yoav Ben‐Shlomo, et al.. (2022). Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank. PLoS ONE. 17(11). e0276781–e0276781. 6 indexed citations

11.

Kulkarni, Spoorthy, et al.. (2022). Efficacy of pharmacological management of orthostatic hypotension- a systematic review and meta-analysis.

12.

Weiss, Anne, James Goodman, Marie Fisk, et al.. (2022). Niclosamide—A promising treatment for COVID‐19. British Journal of Pharmacology. 179(13). 3250–3267. 61 indexed citations

13.

Kulkarni, Spoorthy, Mark Glover, Vikas Kapil, et al.. (2022). Management of hypertensive crisis: British and Irish Hypertension Society Position document. Journal of Human Hypertension. 37(10). 863–879. 27 indexed citations

14.

Kulkarni, Spoorthy, Anna F. Dominiczak, Rhian M. Touyz, et al.. (2021). CONNed in Pregnancy. Hypertension. 78(1). 241–249. 1 indexed citations

15.

Kulkarni, Spoorthy, et al.. (2021). Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension. Medicine. 100(14). e24654–e24654. 18 indexed citations

16.

Adeyeye, Elizabeth, et al.. (2021). Sustainable medicines use in clinical practice: A clinical pharmacological view on eco‐pharmaco‐stewardship. British Journal of Clinical Pharmacology. 88(7). 3023–3029. 11 indexed citations

17.

Kulkarni, Spoorthy, et al.. (2020). Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms. SHILAP Revista de lepidopterología. 2020. 1–6. 2 indexed citations

18.

Kulkarni, Spoorthy. (2020). Hypertension management in 2030: a kaleidoscopic view. Journal of Human Hypertension. 35(9). 812–817. 11 indexed citations

19.

Kulkarni, Spoorthy, et al.. (2020). COVID-19 and hypertension. Journal of the Renin-Angiotensin-Aldosterone System. 21(2). 2691651691–2691651691. 30 indexed citations

20.

Kulkarni, Spoorthy & L LaGrenade. (1992). Ehlers-Danlos syndrome in pregnancy.. PubMed. 41(2). 86–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact